APO Research
Talk to an analyst

APO RESEARCH · REPORT

Naldemedine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Naldemedine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025172 pages

Choose your research edition.

Industry ResearchNaldemedine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Naldemedine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Naldemedine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Naldemedine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Naldemedine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Naldemedine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Naldemedine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Naldemedine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Naldemedine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Naldemedine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Naldemedine include Purdue Pharma and Shionogi among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Naldemedine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Naldemedine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Naldemedine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Naldemedine market size, projected growth trends, production technologies, key applications, and end-use industries.

Naldemedine Segment by Company

Purdue Pharma

Shionogi

Naldemedine Segment by Type

Self-production API

Outsourcing of API

Naldemedine Segment by Application

Clinic

Hospital

Drug Center

Others

Naldemedine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Naldemedine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Naldemedine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Naldemedine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Naldemedine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Naldemedine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Naldemedine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Naldemedine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Naldemedine Industry Trends Table 2. Naldemedine Industry Drivers Table 3. Naldemedine Industry Opportunities and Challenges Table 4. Naldemedine Industry Restraints Table 5. Global Naldemedine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Naldemedine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Naldemedine Sales by Manufacturers (k pcs) & (2021-2026) Table 8. Global Naldemedine Sales Market Share by Manufacturers Table 9. Global Naldemedine Average Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 10. Global Naldemedine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Naldemedine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Naldemedine Manufacturers, Product Type & Application Table 13. Global Naldemedine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Naldemedine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Self-production API Table 17. Major Manufacturers of Outsourcing of API Table 18. Global Naldemedine Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 19. Global Naldemedine Sales by Type (2021-2026) & (k pcs) Table 20. Global Naldemedine Sales by Type (2027-2032) & (k pcs) Table 21. Global Naldemedine Sales Market Share by Type (2021-2026) Table 22. Global Naldemedine Sales Market Share by Type (2027-2032) Table 23. Global Naldemedine Revenue by Type 2021 VS 2025 VS 2032 (k pcs) Table 24. Global Naldemedine Revenue by Type (2021-2026) & (k pcs) Table 25. Global Naldemedine Revenue by Type (2027-2032) & (k pcs) Table 26. Global Naldemedine Revenue Market Share by Type (2021-2026) Table 27. Global Naldemedine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Clinic Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Drug Center Table 31. Major Manufacturers of Others Table 32. Global Naldemedine Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 33. Global Naldemedine Sales by Application (2021-2026) & (k pcs) Table 34. Global Naldemedine Sales by Application (2027-2032) & (k pcs) Table 35. Global Naldemedine Sales Market Share by Application (2021-2026) Table 36. Global Naldemedine Sales Market Share by Application (2027-2032) Table 37. Global Naldemedine Revenue by Application 2021 VS 2025 VS 2032 (k pcs) Table 38. Global Naldemedine Revenue by Application (2021-2026) & (k pcs) Table 39. Global Naldemedine Revenue by Application (2027-2032) & (k pcs) Table 40. Global Naldemedine Revenue Market Share by Application (2021-2026) Table 41. Global Naldemedine Revenue Market Share by Application (2027-2032) Table 42. Global Naldemedine Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 43. Global Naldemedine Sales by Region (2021-2026) & (k pcs) Table 44. Global Naldemedine Sales Market Share by Region (2021-2026) Table 45. Global Naldemedine Sales Forecasted by Region (2027-2032) & (k pcs) Table 46. Global Naldemedine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Naldemedine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 48. North America Naldemedine Sales by Country (2021-2026) & (k pcs) Table 49. North America Naldemedine Sales by Country (2027-2032) & (k pcs) Table 50. Europe Naldemedine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 51. Europe Naldemedine Sales by Country (2021-2026) & (k pcs) Table 52. Europe Naldemedine Sales by Country (2027-2032) & (k pcs) Table 53. Asia Pacific Naldemedine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 54. Asia Pacific Naldemedine Sales by Country (2021-2026) & (k pcs) Table 55. Asia Pacific Naldemedine Sales by Country (2027-2032) & (k pcs) Table 56. South America, Middle East and Africa Naldemedine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 57. South America, Middle East and Africa Naldemedine Sales by Country (2021-2026) & (k pcs) Table 58. South America, Middle East and Africa Naldemedine Sales by Country (2027-2032) & (k pcs) Table 59. Global Naldemedine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Naldemedine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Naldemedine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Naldemedine Revenue Market Share by Region (2021-2026) Table 63. Global Naldemedine Revenue Market Share by Region (2027-2032) Table 64. Purdue Pharma Company Information Table 65. Purdue Pharma Business Overview Table 66. Purdue Pharma Naldemedine Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Purdue Pharma Naldemedine Product Portfolio Table 68. Purdue Pharma Recent Development Table 69. Shionogi Company Information Table 70. Shionogi Business Overview Table 71. Shionogi Naldemedine Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Shionogi Naldemedine Product Portfolio Table 73. Shionogi Recent Development Table 74. Key Raw Materials Table 75. Raw Materials Key Suppliers Table 76. Naldemedine Distributors List Table 77. Naldemedine Customers List Table 78. Research Programs/Design for This Report Table 79. Authors List of This Report Table 80. Secondary Sources Table 81. Primary Sources List of Figures Figure 1. Naldemedine Product Image Figure 2. Global Naldemedine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Naldemedine Market Size (2021-2032) & (US$ Million) Figure 4. Global Naldemedine Sales (2021-2032) & (k pcs) Figure 5. Global Naldemedine Average Price (US$/pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Naldemedine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Self-production API Image Figure 9. Outsourcing of API Image Figure 10. Global Naldemedine Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 11. Global Naldemedine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Naldemedine Sales Market Share by Type (2021-2032) Figure 13. Global Naldemedine Revenue by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 14. Global Naldemedine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Naldemedine Revenue Market Share by Type (2021-2032) Figure 16. Clinic Image Figure 17. Hospital Image Figure 18. Drug Center Image Figure 19. Others Image Figure 20. Global Naldemedine Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 21. Global Naldemedine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Naldemedine Sales Market Share by Application (2021-2032) Figure 23. Global Naldemedine Revenue by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 24. Global Naldemedine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Naldemedine Revenue Market Share by Application (2021-2032) Figure 26. North America Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 27. North America Naldemedine Sales Market Share by Country (2021-2032) Figure 28. U.S. Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 29. Canada Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 30. Mexico Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 31. Europe Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 32. Europe Naldemedine Sales Market Share by Country (2021-2032) Figure 33. Germany Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 34. France Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 35. U.K. Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 36. Italy Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 37. Netherlands Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 38. Asia Pacific Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 39. Asia Pacific Naldemedine Sales Market Share by Country (2021-2032) Figure 40. China Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 41. Japan Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 42. South Korea Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 43. Southeast Asia Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 44. India Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 45. Australia Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 46. South America, Middle East and Africa Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 47. South America, Middle East and Africa Naldemedine Sales Market Share by Country (2021-2032) Figure 48. Brazil Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 49. South Africa Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 50. Saudi Arabia Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 51. Turkey Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 52. Argentina Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 53. UAE Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 54. Egypt Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 55. Chile Naldemedine Sales and Growth Rate (2021-2032) & (k pcs) Figure 56. Global Naldemedine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Naldemedine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Naldemedine Revenue (2021-2032) & (US$ Million) Figure 59. North America Naldemedine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Naldemedine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Naldemedine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Naldemedine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Naldemedine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Naldemedine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Naldemedine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Naldemedine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Naldemedine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Self-production API
  • Outsourcing of API
Applications
  • Clinic
  • Hospital
  • Drug Center
  • Others
Companies covered
  • Purdue Pharma
  • Shionogi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Naldemedine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Naldemedine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Naldemedine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Naldemedine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Naldemedine Market Dynamics
  1. 2.1 Naldemedine Industry Trends
  2. 2.2 Naldemedine Industry Drivers
  3. 2.3 Naldemedine Industry Opportunities and Challenges
  4. 2.4 Naldemedine Industry Restraints
3 Naldemedine Market by Manufacturers
  1. 3.1 Global Naldemedine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Naldemedine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Naldemedine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Naldemedine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Naldemedine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Naldemedine Manufacturers, Product Type & Application
  7. 3.7 Global Naldemedine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Naldemedine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Naldemedine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Naldemedine Tier 1, Tier 2, and Tier 3
4 Naldemedine Market by Type
  1. 4.1 Naldemedine Type Introduction
  2. 4.1.1 Self-production API
  3. 4.1.2 Outsourcing of API
  4. 4.2 Global Naldemedine Sales by Type
  5. 4.2.1 Global Naldemedine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Naldemedine Sales by Type (2021-2032)
  7. 4.2.3 Global Naldemedine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Naldemedine Revenue by Type
  9. 4.3.1 Global Naldemedine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Naldemedine Revenue by Type (2021-2032)
  11. 4.3.3 Global Naldemedine Revenue Market Share by Type (2021-2032)
5 Naldemedine Market by Application
  1. 5.1 Naldemedine Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Drug Center
  5. 5.1.4 Others
  6. 5.2 Global Naldemedine Sales by Application
  7. 5.2.1 Global Naldemedine Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Naldemedine Sales by Application (2021-2032)
  9. 5.2.3 Global Naldemedine Sales Market Share by Application (2021-2032)
  10. 5.3 Global Naldemedine Revenue by Application
  11. 5.3.1 Global Naldemedine Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Naldemedine Revenue by Application (2021-2032)
  13. 5.3.3 Global Naldemedine Revenue Market Share by Application (2021-2032)
6 Global Naldemedine Sales by Region
  1. 6.1 Global Naldemedine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Naldemedine Sales by Region (2021-2032)
  3. 6.2.1 Global Naldemedine Sales by Region (2021-2026)
  4. 6.2.2 Global Naldemedine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Naldemedine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Naldemedine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Naldemedine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Naldemedine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Naldemedine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Naldemedine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Naldemedine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Naldemedine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Naldemedine Revenue by Region
  1. 7.1 Global Naldemedine Revenue by Region
  2. 7.1.1 Global Naldemedine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Naldemedine Revenue by Region (2021-2026)
  4. 7.1.3 Global Naldemedine Revenue by Region (2027-2032)
  5. 7.1.4 Global Naldemedine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Naldemedine Revenue (2021-2032)
  8. 7.2.2 North America Naldemedine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Naldemedine Revenue (2021-2032)
  11. 7.3.2 Europe Naldemedine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Naldemedine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Naldemedine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Naldemedine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Naldemedine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Purdue Pharma
  2. 8.1.1 Purdue Pharma Company Information
  3. 8.1.2 Purdue Pharma Business Overview
  4. 8.1.3 Purdue Pharma Naldemedine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Purdue Pharma Naldemedine Product Portfolio
  6. 8.1.5 Purdue Pharma Recent Developments
  7. 8.2 Shionogi
  8. 8.2.1 Shionogi Company Information
  9. 8.2.2 Shionogi Business Overview
  10. 8.2.3 Shionogi Naldemedine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shionogi Naldemedine Product Portfolio
  12. 8.2.5 Shionogi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Naldemedine Value Chain Analysis
  2. 9.1.1 Naldemedine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Naldemedine Production Mode & Process
  6. 9.2 Naldemedine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Naldemedine Distributors
  9. 9.2.3 Naldemedine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst